It could be said that the word “miracle” is overused in today’s society. But when a baby is born with most of his skull and brain missing and survives, it’s hard to call it anything but.
Guava leaves are just as medicinally useful as the nutritional powerhouse fruit they grow with. The leaves of the guava tree are full of antioxidants, anti-inflammatory agents, antibacterials, and even tannins that can have significant health benefits, from treating stomach troubles to chronic diseases like cancer.
The average wait time for general surgery in Costa Rica’s public hospitals is 452 days, and in nearly all cases patients must wait at least 90 days, according to the latest data released by Costa Rica’s public health and social security administration, known as CCSS or “La Caja,” based on figures from 2014.
While the move has been applauded by many, the decree leaves Costa Rica’s public health and social security administration, known as CCSS or “La Caja,” just two years to find more than US $450 million per year in additional budget to pay for the for more than 3,000 couples that are expected to turn to the public health system to receive the procedure each year, according to estimates made by CCSS in July.
The Costa Rican public health and social security administration known as CCSS or La Caja estimates that it will spend some ¢60 million (about US $112,000) per patient that undergoes in vitro fertilization (IVF) treatment between the time that fertility treatment is begun and a baby is successfully born, Health Minister Fernando Llorca told Amelia Rueda.
Workers and medical staff at the public Hospital La Anexión in Nicoya will begin an “indefinite” strike at 6 a.m. on Tuesday in protest against the privatization of cleaning and security services at the hospital, services that the hospital plans to turn over to private contractors.
The Solis administration released a draft decree on Thursday morning authorizing in-vitro fertilization (IVF) in public and private medical centers.
The draft decree was sent Thursday morning to the Board of Physicians and the country’s social security and public health administration known as CCSS for review, with President Solis promising to sign the decree within five days.
When taking a medication, it’s important to weigh the risk of side effects against its potential benefits. But when it comes to common drugs being used to treat prostate enlargement and hair loss, sometimes the potential health risks can’t be ignored. Researchers from Boston University Medical Center are finding that twenty-five percent of men taking Finasteride or Dutasteride, more commonly known as Proscar and Avodart, for benign prostate enlargement (BPH) may not be receiving any benefit at all, while those taking Procepia (also made from the same formula) or Avodart for male pattern hair loss may be experiencing more adverse effects than benefits.